enGene enrolls patients with non-muscle invasive bladder cancer in phase I/II study of EG-70 March 22, 2021
Exelixis collaborates with Merck KGaA and Pfizer to evaluate XL-092 plus avelumab in UC March 19, 2021
Clinical trial collaboration supports new phase II study of Tabrecta and Nerlynx in breast cancer March 17, 2021
RSS